Minerva Common Stock Total Equity vs Common Stock Analysis
NERV Stock | USD 2.55 0.22 9.44% |
Minerva Neurosciences financial indicator trend analysis is infinitely more than just investigating Minerva Neurosciences recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Minerva Neurosciences is a good investment. Please check the relationship between Minerva Neurosciences Common Stock Total Equity and its Common Stock accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Minerva Neurosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.
Common Stock Total Equity vs Common Stock
Common Stock Total Equity vs Common Stock Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Minerva Neurosciences Common Stock Total Equity account and Common Stock. At this time, the significance of the direction appears to have strong relationship.
The correlation between Minerva Neurosciences' Common Stock Total Equity and Common Stock is 0.61. Overlapping area represents the amount of variation of Common Stock Total Equity that can explain the historical movement of Common Stock in the same time period over historical financial statements of Minerva Neurosciences, assuming nothing else is changed. The correlation between historical values of Minerva Neurosciences' Common Stock Total Equity and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Total Equity of Minerva Neurosciences are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Common Stock Total Equity i.e., Minerva Neurosciences' Common Stock Total Equity and Common Stock go up and down completely randomly.
Correlation Coefficient | 0.61 |
Relationship Direction | Positive |
Relationship Strength | Significant |
Common Stock Total Equity
The total value of common stock equity held by shareholders, representing their ownership interest in the company.Common Stock
Most indicators from Minerva Neurosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Minerva Neurosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Minerva Neurosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.At this time, Minerva Neurosciences' Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to climb to 0.00 in 2024, whereas Enterprise Value Over EBITDA is likely to drop (3.68) in 2024.
2023 | 2024 (projected) | Extraordinary Items | 8.5M | 7.5M | Reconciled Depreciation | 29.6K | 57.8K |
Minerva Neurosciences fundamental ratios Correlations
Click cells to compare fundamentals
Minerva Neurosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Minerva Neurosciences fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 77.5M | 57.6M | 77.1M | 55.1M | 56.9M | 88.0M | |
Other Current Liab | (41.2B) | 2.1M | 965.7K | 407.9K | 1.5M | 1.6M | |
Total Current Liabilities | 6.6M | 3.2M | 2.8M | 1.4M | 3.3M | 4.4M | |
Total Stockholder Equity | 27.8M | 52.7M | 8.0M | (20.0M) | (28.5M) | (27.0M) | |
Net Debt | (21.1M) | (25.2M) | (60.8M) | 37.6M | 41.0M | 43.1M | |
Retained Earnings | (286.7M) | (284.8M) | (334.7M) | (366.8M) | (396.8M) | (377.0M) | |
Cash | 21.4M | 25.4M | 60.8M | 36.1M | 41.0M | 34.7M | |
Cash And Short Term Investments | 45.9M | 25.4M | 60.8M | 36.1M | 41.0M | 51.4M | |
Common Stock Total Equity | 3.9K | 3.9K | 3.9K | 4.3K | 4.9K | 3.0K | |
Common Stock Shares Outstanding | 4.9M | 5.1M | 5.3M | 5.3M | 6.5M | 4.6M | |
Liabilities And Stockholders Equity | 77.5M | 57.6M | 77.1M | 55.1M | 56.9M | 88.0M | |
Other Current Assets | 1.3B | 2.1B | 1.4B | 4.0M | 989.9K | 940.4K | |
Other Stockholder Equity | 314.5M | 337.5M | 342.7M | 346.8M | 368.4M | 264.5M | |
Total Liab | 49.7M | 5.0M | 69.1M | 75.1M | 85.4M | 42.7M | |
Total Current Assets | 47.1M | 27.4M | 62.2M | 40.2M | 42.0M | 52.9M | |
Common Stock | 3.9K | 4K | 4.3K | 534.0 | 699.0 | 664.05 | |
Property Plant And Equipment Net | 278K | 101.8K | 51.1K | 16.3K | 10.9K | 10.3K | |
Accounts Payable | 2.3M | 995.6K | 1.9M | 969.7K | 1.8M | 1.5M | |
Non Current Assets Total | 30.4M | 30.2M | 14.9M | 14.9M | 14.9M | 27.9M | |
Non Current Liabilities Total | 43.1M | 1.8M | 66.3M | 73.7M | 82.0M | 41.8M | |
Property Plant And Equipment Gross | 278.0K | 101.8K | 0.0 | 16.3K | 18.8K | 17.8K | |
Short Term Debt | 4.0M | 41.2B | 173K | 111.2K | 127.9K | 121.5K | |
Property Plant Equipment | 33.5K | 16.0K | 101.8K | 16.3K | 18.8K | 36.8K | |
Other Liab | 43.0M | 1.8M | 66.3M | 73.7M | 84.8M | 89.0M | |
Net Tangible Assets | (2.3M) | 22.6M | (6.9M) | (34.9M) | (31.4M) | (29.9M) | |
Retained Earnings Total Equity | (164.4M) | (214.6M) | (286.7M) | (284.8M) | (256.3M) | (269.1M) | |
Capital Surpluse | 296.0M | 304.8M | 314.5M | 337.5M | 388.1M | 278.9M | |
Non Current Liabilities Other | 41.2M | 41.3M | 66.3M | 73.7M | 82.0M | 41.9M | |
Net Invested Capital | 27.8M | 52.7M | 8.0M | (20.0M) | (28.5M) | (27.0M) | |
Net Working Capital | 40.5M | 24.3M | 59.4M | 38.8M | 38.7M | 46.9M |
Pair Trading with Minerva Neurosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Minerva Neurosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Minerva Neurosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Minerva Stock
0.81 | EQ | Equillium | PairCorr |
The ability to find closely correlated positions to Minerva Neurosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Minerva Neurosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Minerva Neurosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Minerva Neurosciences to buy it.
The correlation of Minerva Neurosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Minerva Neurosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Minerva Neurosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Minerva Neurosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Minerva Neurosciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Minerva Stock analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |
Is Minerva Neurosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Minerva Neurosciences. If investors know Minerva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Minerva Neurosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.43) | Return On Assets (0.30) | Return On Equity (6.75) |
The market value of Minerva Neurosciences is measured differently than its book value, which is the value of Minerva that is recorded on the company's balance sheet. Investors also form their own opinion of Minerva Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Minerva Neurosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Minerva Neurosciences' market value can be influenced by many factors that don't directly affect Minerva Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Minerva Neurosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Minerva Neurosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Minerva Neurosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.